Shannon Thyme Klinger has been Group General Counsel of Novartis since 2018. She is a member of the Executive Committee of Novartis.
Ms. Klinger most recently served as Chief Ethics, Risk and Compliance Officer from April to May 2018, and was appointed to the Executive Committee of Novartis in this role. Before that, she was Chief Ethics and Compliance Officer and Global Head of Litigation from 2016 to 2018. She joined Novartis in 2011 as General Counsel for North America at Sandoz Inc., and later served as General Counsel and Global Head of Legal at Sandoz International from 2012 to 2016. Prior to Novartis, Ms. Klinger worked in the United States as a partner at Mayer Brown LLP from 2010 to 2011, and as general counsel and senior vice president at Solvay Pharmaceuticals Inc. from 2008 to 2010.
Ms. Klinger holds a juris doctor with honors from the University of North Carolina at Chapel Hill and a bachelor’s degree in psychology from the University of Notre Dame (both in the US). She is a member of the State Bar of Georgia and of the District of Columbia Bar in the US, and serves on the board of directors of the SIX Group in Switzerland.